Vim Li Cas Xaiv Peb
Khoom siv Advanced
Peb lub tuam txhab muaj cov cuab yeej tsim khoom siab tshaj plaws, ua tiav cov txheej txheem kuaj cov khoom, thiab cov kev lees paub zoo, thiab tam sim no tuav ISO / SGS / FDA / GMP / HALA daim ntawv pov thawj.
Kev Tswj Xyuas Zoo
Siv cov- cov ntaub ntawv zoo thiab tsim kom muaj kev tswj xyuas nruj, muab cov neeg tshwj xeeb los saib xyuas txhua feem ntawm kev tsim khoom, los ntawm kev yuav khoom raw mus rau kev sib dhos.
Pab neeg tshaj lij
Cov kws tshawb fawb ua haujlwm muaj 15 xyoo ntawm kev ua haujlwm hauv kev lag luam cog qoob loo. Ntau yam khoom tshiab raug tso tawm txhua lub hlis.
Tus nqi sib tw
Lub tuam txhab tuaj yeem muab cov nqi sib tw piv rau lawv cov neeg sib tw, ua rau lawv muaj kev xaiv zoo dua rau cov peev nyiaj -cov neeg siv khoom paub meej.
O-304 yog ib qho tshuaj uas tau hais tseg nrog cov mis molecular C₁₆H₁₁Cl₂N₃O₂S thiab molecular hnyav ntawm 380.25 g / mol. Nws cov qauv tsim los cuam tshuam hauv kev tswj hwm lub zog ntawm tes los ntawm kev txhim kho cov haujlwm ntawm AMP-activated protein kinase (AMPK), tus thawj tswj hwm ntawm cellular zog homeostasis.
Tsis zoo li ntau cov kab mob metabolic, O-304 ua haujlwm los ntawm kev tawm tsam cov dephosphorylation ntawm phosphorylated AMPK (pAMPK), yog li txhawb nqa AMPK kev ua si yam tsis tas yuav txo qis ntawm cov cellular ATP. Cov txheej txheem sib txawv no ua rau nws cuam tshuam ntau txoj hauv kev metabolic tseem ceeb rau cov piam thaj metabolism, tswj lipid, thiab kev ua haujlwm ntawm lub plawv.
Cov txiaj ntsig ntawm Retatrutide Peptide
1. Txhim kho Glucose Uptake thiab Insulin Sensitivity
O-304 ua kom cov piam thaj nce ntxiv hauv cov leeg pob txha, cov ntaub so ntswg tseem ceeb rau kev pov tseg cov piam thaj. Qhov kev txiav txim no pab txo qis cov tshuaj insulin-ib qho piv txwv ntawm hom 2 mob ntshav qab zib mellitus (T2D).
Tej zaum qhov tseem ceeb tshaj plaws rau cov kws tshawb fawb, O-304 tau pom tias muaj peev xwm txo tau HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) hauv cov kev tshawb fawb soj ntsuam, tshwj xeeb tshaj yog ua ke nrog cov qauv kev kho mob xws li metformin-underscoring nws lub peev xwm ua ib qho kev hloov pauv hauv metabolic.
2. Txo -Cell Stress
Kev xav tau insulin ntev ntev ua rau -kev ntxhov siab ntawm tes thiab kev ua haujlwm tsis zoo hauv T2D. O-304 tau pom tias ua kom yooj yim rau qhov kev ntxhov siab no, txhawb nqa -cell "so" - qhov muaj txiaj ntsig zoo hauv kev khaws cia ua haujlwm pancreatic.
3. Ua raws li "kev tawm dag zog Mimetic"
Kev ua kom AMPK yog ib qho ntawm cov teebmeem hauv qab ntawm kev tawm dag zog lub cev. O-304 tuaj yeem ua raws li ntau qhov kev tawm dag zog-zoo li cov txiaj ntsig- suav nrog kev txhim kho cov ntshav peripheral thiab txhim kho lub plawv ua haujlwm-ua rau nws muaj txiaj ntsig zoo rau kev tshawb fawb metabolic thiab mob plawv.
Vim li cas cov kws tshawb fawb saib xyuas?
Ntau qhov kev tshawb nrhiav thiab cov ntawv qhia kev kawm qhia tau hais tias muaj kev txaus siab rau cov ntsiab lus xws li "AMPK activators," "kev tshawb fawb metabolic syndrome," "kev kho mob ntshav qab zib hom 2," thiab "kev tawm dag zog mimetics". Cov neeg siv txaus siab rau kev txiav- ntug kev tshawb fawb txog kev noj qab haus huv metabolic tab tom tshawb nrhiav cov tebchaw uas mus dhau cov kev kho mob ib txwm muaj.
O-304 haum squarely rau hauv cov qauv no vim nws:
1.Targets universal metabolic regulator (AMPK) txuas rau kev rog, ntshav qab zib, thiab mob plawv.
2.Qhov kev txhawb nqa los ntawm kev tshawb fawb txog kev kho mob preclinical thiab thaum ntxov qhia pom tias muaj txiaj ntsig zoo rau cov metabolism.
3.Ua rau ntau txoj hauv kev feem ntau hais txog kev noj qab haus huv thiab kev sib tham txog biotech.
Rau kev ywj pheej e- cov neeg ua lag luam, tso O-304 cov ntsiab lus nyob ib puag ncig cov ntsiab lus tshawb fawb tseem ceeb no tuaj yeem tsav tsheb organic los ntawm cov kws tshawb fawb, kws tshaj lij, thiab cov kws tshaj lij kev lag luam.
Kev tshawb fawb thiab kev loj hlob Trends
Cov kws tshuaj thiab cov zej zog biotech nquag nrhiav cov tshiab AMPK activators vim tias lawv muaj peev xwm cuam tshuam rau:
1. Hom 2 Kev Tswj Mob Ntshav Qab Zib: Tshaj li kev tswj cov piam thaj, kev ua kom AMPK tuaj yeem hloov kho tus kab mob.
2.Obesity thiab Fatty Liver Disease: Los ntawm kev txhim kho kev siv hluav taws xob thiab txhim kho lipid metabolism.
3.Cardiovascular Health: Los ntawm cov teebmeem zoo ib yam li kev tawm dag zog.
4.Drug Combinations: Tshawb nrhiav kev sib koom ua ke nrog cov tshuaj uas twb muaj lawm xws li metformin lossis GLP-1 agonists.
O-304 yog ib feem ntawm qhov kev nthuav dav no mus rau cov neeg ua haujlwm metabolic ntau yam. Raws li kev tshawb fawb txuas ntxiv mus, derivatives thiab tiam tom ntej AMPK activators yuav tshwm sim, tab sis O-304 tseem yog ib qho tseem ceeb hauv kev tshawb pom cov kav dej thaum ntxov.
Xian Herben Biotech Co., Ltd. tau tsim nyob rau hauv 2018, nyob rau hauv lub ancient nroog ntawm Tuam Tshoj - Xi'an. Nws yog ib lub tuam txhab muaj kev sib koom ua ke ntawm kev tsim khoom, kev muag khoom thiab kev pabcuam. Tsom ntsoov rau kev kho mob thiab kev ua OEM, feem ntau yog xa tawm cov tshuaj thiab cov ntaub ntawv kho mob, cov nroj tsuag rho tawm, API & Intermedium thiab lwm yam.
Peb lub tuam txhab muaj cov cuab yeej tsim khoom siab heev, cov khoom siv zoo tshaj plaws thiab kev ruaj ntseg zoo, thiab cov ntawv pov thawj ISO / SGS / FDA / GMP / HALA. Muaj pab pawg R & D kws tshaj lij, pab pawg tsim khoom, pab pawg muag khoom thiab tom qab- pab pawg muag khoom. Txij li thaum nws tsim, nws tau ua si nws tus kheej zoo, txhim kho nws cov kev muag khoom network, thiab them nyiaj mloog mus rau lub tuam txhab cov duab, yeej lub qhuas ntawm cov neeg muas zaub. Peb cov khoom tau raug xa tawm mus rau Nyiv, Tebchaws Meskas, Tebchaws Europe, Is Nrias teb, Southeast Asia thiab lwm qhov chaw hauv ntiaj teb. Peb ib txwm ua raws li qhov sib xws ntawm "zoo ua ntej, kev ncaj ncees ua ntej", nyob rau hauv lub siab ntawm "innovation, enterprising", thiab tag nrho lub siab dawb paug muab peb cov neeg muas zaub nrog siab - cov khoom zoo thiab cov kev pab zoo siab.
FAQ
Q: O-304 ua dab tsi ntawm qib molecular?
Q: Cov ntawv thov kev tshawb fawb tseem ceeb rau O-304 yog dab tsi?
- Cov kab mob metabolic xws li ntshav qab zib hom 2 thiab insulin tsis kam.
- Kev ua haujlwm ntawm cov hlab plawv cuam tshuam nrog microvascular perfusion.
- Lub siab metabolism thiab MASLD (fatty siab kab mob) hauv cov qauv ua ntej.
- Lub zog tswj txoj hauv kev thiab cov xov tooj ntawm tes taw tes khi rau AMPK.
Nws yog qhov tseem ceeb hauv kev tshawb fawb preclinical soj ntsuam kev hloov pauv hauv metabolic thiab cov lus teb kev ntxhov siab. Cov kev tshawb fawb tsis ntev los no kuj qhia txog qhov cuam tshuam ntawm kev faib cov lipid thiab lub siab metabolic programming.
Q: Yuav ua li cas O-304 yuav khaws thiab tuav?
O-304 feem ntau yog muab los ua cov hmoov crystalline. Cov txheej txheem tshawb fawb Standard muaj xws li:
- Cia: hmoov daim ntawv ntawm −20℃rau ntev -lub sij hawm stability.
- Hauv cov kuab tshuaj: Cov tshuaj khaws cia ntawm −80℃(pom zoo) lossis −20℃rau lub sijhawm luv.
- Solubility: Soluble hauv DMSO thiab cov organic solvents zoo sib xws; Thaum tshav kub kub thiab sonication tuaj yeem pab yaj nws.
Cim npe nrov: atx-304, Tuam Tshoj atx-304 manufacturers, lwm tus neeg, Hoobkas
